Lumexa Imaging (LMRI) priced 25M shares at $18.50. The deal priced at the midpoint of the $17.00-$20.00 target range. Barclays, JPMorgan and Jefferies are acting as joint book running managers for the offering. Lumexa Imaging is a provider of diagnostic imaging services whose affiliates operated the second largest outpatient imaging center footprint in the United States as of September 30, spanning 184 centers across 13 states.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LMRI: